Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction
Connie R. Shi, Michael F. Shaughnessy, Kartik Sehgal, John R. Clark, Kerry L. Reynolds, Jennifer Toyohara, Steven T. Chen
Topics & Concepts
MedicineEmergency departmentPembrolizumabFamily medicineGeneral hospitalDermatologyInternal medicineCancerImmunotherapyPsychiatryDrug-Induced Adverse ReactionsCAR-T cell therapy researchChemotherapy-related skin toxicity